T-cell Leukemia Lymphoma
📧 Sign up to get email alerts when something new happens for T-cell Leukemia Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
NCI-sponsored clinical trial update describes collecting human samples to study hairy cell leukemia and other leukemias, and to develop reco…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Tissue Collection for Studies of Lymph Cancer
Clinical trial update describing tissue collection for studies of lymph cancers; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma [Phase 2]
An ongoing Phase 2 study evaluating maintenance therapy with ruxolitinib after hematopoietic stem cell transplant in patients with T-cell ly…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
This clinical trial update describes biospecimen procurement for the Center for Immuno-Oncology immunotherapy protocols. It covers recruitin…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL) [Phase 1]
Phase 1 trial updating the addition of lenalidomide to the EPOCH chemotherapy regimen for adult T-cell leukemia/lymphoma; the study is curre…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma [Phase 1]
Phase 1 trial evaluating azacitidine with abatacept for relapsed or refractory T-cell lymphomas is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Clinico-biological Characterization and Survival of Patients With Adult T-cell Leukemia / Lymphoma (ATL) and Patients Chronically Infected With the HTLV-1 Virus (HTLV-OBS)
The document provides an update on a study assessing clinico-biological features and survival in adults with HTLV-1–associated adult T-cell …
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma [Phase 2]
Phase 2 trial evaluating belinostat in combination with zidovudine for adult T-cell leukemia/lymphoma has completed and results have been po…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1 [Phase 2]
Phase 2 trial of mogamulizumab to prevent adult T-cell leukemia/lymphoma in HTLV-1–infected individuals; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: A Phase I/II Study of ASTX660 in Patients With Relapsed or Refractory T-cell Lymphoma [Phase 1, Phase 2]
Phase I/II study of ASTX660 in relapsed or refractory T-cell lymphomas has been terminated; results have been posted.
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma [Phase 1]
A Phase 1 trial evaluating third-party allogeneic natural killer cells together with mogamulizumab for relapsed or refractory adult T-cell l…
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (<10%) Mature T Cell Lymphoma (TCL) [Phase 2]
This Phase II study evaluates single-agent Brentuximab Vedotin in relapsed/refractory CD30-low mature T-cell lymphomas; the trial has comple…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: A Phase I/II Study of OJP-001 in Patients With Adult T-cell Leukemia/Lymphoma [Phase 1, Phase 2]
A Phase I/II clinical trial evaluating OJP-001 in adults with Adult T-cell leukemia/lymphoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Venetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like Patients [Phase 2]
Phase 2 clinical trial evaluating a venetoclax-based combination with azacitidine, chidamide, vindesine, and dexamethasone in newly diagnose…
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: A Registry for People With T-cell Lymphoma
A registry study at Memorial Sloan Kettering Cancer Center to enroll people with various T-cell and NK-cell lymphomas; the trial is currentl…
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies [Phase 1]
This clinical trial update describes a Phase 1 dose-escalation and dose-expansion study of anti-CD7 allogeneic CAR T-cells (WU-CART-007) in …
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)
The document reports a completed clinical trial evaluating lenalidomide (Revlimid) for relapsed or refractory adult T-cell leukemia/lymphoma…
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma [Phase 2]
Phase 2 trial results for BV-CHEP chemotherapy in adults with adult T-cell leukemia/lymphoma and lymphoma have been posted.
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: Valemetostat Tosylate (DS-3201b) Phase 2 Study in Relapsed or Refractory Adult T-cell Leukemia/Lymphoma [Phase 2]
Valemetostat tosylate (DS-3201b) Phase 2 study in relapsed or refractory Adult T-cell Leukemia/Lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Efficacy and Safety of Oral HBI-8000 in Patients With Relapsed or Refractory Adult T Cell Lymphoma (ATL) [Phase 2]
Phase 2 trial evaluating oral HBI-8000 in relapsed or refractory adult T-cell leukemia/lymphoma reports efficacy and safety results.
-
CLINICAL_TRIALS safety_alert · 2024-07-24Clinical Trial Update: Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab
A post-authorization safety study is evaluating safety outcomes of allogeneic hematopoietic stem cell transplantation in patients previously…
-
CLINICAL_TRIALS trial_result · 2024-07-22Clinical Trial Update: Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01) [Phase 2]
Daiichi Sankyo reported an update on valemetostat tosylate (DS-3201b), an EZH1/2 dual inhibitor, in a Phase 2 trial (VALENTINE-PTCL01) for r…
-
CLINICAL_TRIALS trial_result · 2023-04-19Clinical Trial Update: Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma [Phase 2]
Phase 2 trial evaluating brentuximab vedotin in combination chemotherapy for CD30-positive peripheral T-cell lymphomas reports results poste…
-
CLINICAL_TRIALS trial_result · 2021-12-14Clinical Trial Update: Phase I Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for People With Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary Syndrome [Phase 1]
Phase I trial evaluating recombinant human IL-15 in combination with mogamulizumab for refractory/relapsed adult T-cell leukemia/lymphoma an…
-
CLINICAL_TRIALS trial_result · 2020-03-23Clinical Trial Update: Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating everolimus and lenalidomide in relapsed or refractory non-Hodgkin or Hodgkin lymphoma; results posted.